“johnson-johnson” Archives

Entry Author Date Location
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
J&J Opens Medical Device Center, Forms Partnerships With Hospitals 10/18/16 Texas
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva 09/20/16 New York
In Wake Of Infamous Biotech Party, 20 Women Join New Exec Training 08/23/16 National
With New Name and $86M, Tioma To Explore Anti-CD47 Cancer Therapy 08/16/16 San Francisco
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble 07/26/16 Boston
Titan Spine CEO: New Medical Billing Code Will Be ‘Big Selling Point’ 07/19/16 Wisconsin
With Bugs As Drugs, Evelo CEO Plans Immune, Cancer Trials in 2017 07/12/16 Boston
Bone-Healing Therapies Firm Bioventus Files for IPO 06/30/16 Raleigh Durham
Fred Lee, The UW Radiologist With Startup Vision 06/29/16 Wisconsin
OrthoPediatrics Bones Up on IPO for Children’s Medical Devices 06/20/16 Indiana
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Wantable, Gener8tor, and Arrowhead: This Week’s Wisconsin Watchlist 03/14/16 Wisconsin
NeuWave Bought by J&J Subsidiary Ethicon, Eyes International Markets 03/10/16 Wisconsin
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
With J&J Deal, Emulate Nabs First Partner For Organ on Chip Tech 06/18/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Xconomy Boston’s Top Stories of Q1 2015: Editor’s Picks 04/01/15 Boston
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More 03/27/15 San Diego
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
Page 1 of 13 next page »